Translate this page into:
Role of impaction bone grafting of allografts in the management of benign lesions of the proximal femur
∗Corresponding author: Raja Bhaskara Rajasekaran. rajabhaskar.ortho@gmail.com
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
The use of allografts to reconstruct benign lesions of the proximal femur after curettage has seldom been reported. We report our experience of impaction bone grafting of only allografts combined with osteosynthesis to manage benign lesions involving the proximal femur.
Between 2013 and 2019, 35 patients of a mean age of 23.8 years (14–41) who had a biopsy proven benign pathology and a median pre-operative Mirels’ score of 9 (8–11) were managed using extended curettage, impaction bone grafting of allografts combined with osteosynthesis through a lateral approach. Radiographs were assessed to see for any recurrence at follow-ups, and functional outcomes were assessed using Musculoskeletal Tumour Society (MSTS) score and Harris hip score (HHS).
At a mean follow-up was 41.5 months (23–80), patients demonstrated favorable functional outcomes with a mean MSTS of 28.3 (18–30) and a mean HHS of 94.3 (66–100) at the last follow-up. Two cases (GCT = 1; fibrous dysplasia = 1) had a recurrence of disease. Allografts demonstrated a particular integration pattern on radiographs that involved an intermediate period of lucency followed by consolidation and integration with the parent bone.
Impaction grafting of allografts in benign lesions of the proximal femur allows adequate bony consolidation of the cavity after extended curettage and can be effectively used as a permanent solution to manage such lesions in most cases. The intermediate period of lucency seen on radiographs must not be confused for recurrence, and patients must be followed up continuously.
Retrospective Case Series.
Level IV.
Keywords
Benign lesion
Proximal femur
Allografts
Impaction bone grafting
1 Introduction
Benign lesions involving the femoral neck are not uncommon in one's clinical practice and these conditions have a high risk of pathological fracture.1,2 Most of these lesions occur in young and active individuals.1–3 While surgery is recommended, there is still a dilemma regarding whether to apply a fixation device or not and the choice of grafts used to augment the defect after curettage.2–5 Literature has shown that while all authors concur on salvaging the femoral head and providing adequate disease clearance, they vary on the choice of the reconstructive modality of the curetted cavity.1–6 While good results have been shown employing autografts with or without fixation devices, these procedures are always associated with donor site morbidity.1,3,5 Use of allografts has traditionally been associated with slow incorporation, low immunogenicity, and increased infection rate but they have been seldom used to manage benign lesions of the proximal femur.4,6 It is doubtful if allografts will fulfill bone incorporation of these defects after curettage. Providing adequate disease clearance by extended curettage, reconstruction of the defect with appropriate bone grafts combined with stabilization using a fixation device would help in decreasing chances of recurrence, prevent a pathological fracture and also ensure early mobilization of the patient.
We hypothesized that impaction bone grafting (IBG)7 – tight packing of contained cavity defect with compressed particulate bone grafts - of gamma-irradiated morselized allografts into the femoral neck after extended curettage coupled with a fixation device through a single lateral approach would benefit the patients with regards to adequate disease clearance and decreased surgical morbidity. Patients would also benefit from the restoration of the defect cavity after curettage. We employed this novel technique in managing benign lesions of the proximal femur at our institution from 2013 and we present our experience in this article.
2 Materials & methods
After obtaining approval from our Institutional review board (IRB), we retrospectively reviewed all the consecutive cases of benign lesions of the proximal femur managed with extended curettage followed by IBG of allografts and stabilization with an implant at our institution. Between 2013 and 2019, 35 consecutive patients – 21 males and 14 females - who had a biopsy proven diagnosis of a benign lesion in the proximal femur were managed using this technique (Table 1). Pain, impending pathological fracture, and a Mirels' score of 8 and above were taken as indications for surgery. Clinical decision regarding pain and discussion in a multidisciplinary meeting to decide to operate in all cases.8 The mean age of the study group was 23.8 years (14–41) with a median Mirels’ score of 9 (8–11) at presentation. All patients were evaluated with an anteroposterior and lateral radiograph of the affected hip joint, an MRI, and were also subjected to fluoroscopic guided needle biopsy through a lateral approach to establish a confirmatory diagnosis. The histological diagnosis was fibrous dysplasia (FD) in 17 cases (49%), aneurysmal bone cyst (ABC) in 5 (14%), chondromyxoid fibroma (CMF) in 4 (11%), chondroblastoma in 4 (11%), giant cell tumour (GCT) in 3 (9%) and simple bone cyst (SBC) in 2 (6%). The mean interval time between biopsy and surgery was 7.4 (5–14) days.
| Mean age (in years) | 23.8 (14–41) |
| Gender (M:F) | 21:14 (60%:40%) |
| Histological Diagnosis | Fibrous dysplasia – 17 (49%)Aneurysmal bone cyst – 5 (14%)Chondromyxoid Fibroma – 4 (11%)Chondroblastoma – 4 (11%)GCT – 3 (9%)Simple bone cyst – 2 (6%) |
| Complications | Oncological relatedRecurrence - 2 (6%) |
| Non-oncological related(includes implant associated complications)Superficial Infection – 2 (6%)Abductor lurch – 2 (6%)Implant removal due to irritation – 1 (3%) |
2.1 Procurement & preparation of allografts
Allografts were procured and processed in the government-approved tissue bank in our institution formed on the guidelines issued in the Transplantation of Human Organs Act, 1994.9 A standard procedure is followed for the procurement and processing of grafts.10 All grafts are harvested from either live donors or cadavers. The femoral head and tibial slices are retrieved from joint replacement surgeries intraoperatively under sterile conditions and long bones are harvested from amputated limbs and cadavers after fulfilling donor selection criteria and obtaining informed consent. All donated bones are processed through a thorough screening process. Then the bones are pasteurized at 60 °C for 3 h, vigorously washed, cleaned of all soft tissue, and cut into the required shapes and sizes. They are subsequently washed free of blood and bone marrow using jet lavage and placed in 70% ethanol for 1 h. The cleaned bones are freeze-dried to remove 95% of the moisture. They are then subjected to gamma irradiation (25 K Gy). Following irradiation, the allografts are packed and stored at - 80 °C in the tissue bank for further use.
2.2 Surgical technique
All surgeries were done under spinal anaesthesia with the patient positioned in a fracture table. A prophylactic antibiotic of 1.5 g intravenous cefuroxime was given on induction. Under image intensifier guidance, the hip joint and the proximal femur are scanned and a lateral incision including the biopsy scar is taken. Through the lateral approach, dissection is made through the tensor fascia lata. After elevating the vastus lateralis anteriorly, the required portion of the lateral cortex of the proximal was exposed. By drilling the lateral cortex, a cortical window is made to gain access to the lesion. Through the window, the lesion is accessed. The window must be wide enough to allow adequate disease clearance and curetting is done until the underlying normal bone is seen. A high-speed burr (60,000 RPM) is used to burr the underlying bone in appropriate cases where it was required. Hydrogen peroxide is used as an adjuvant in all cases and a thorough wash of the underlying cavity is done. Following that the technique of IBG was used to reconstruct the curetted cavity in the proximal femur.7
The allografts were then morselized, packed into a metallic barrel and the graft is delivered into the cavity in the proximal femur (Fig. 1). Once the graft is delivered, a guidewire is passed through the center of the femoral neck. An 8-mm inner reamer is passed over the guide pin in the forward direction, and then reverse reaming is done while removing the reamer. A similar procedure of delivering allograft, reaming, and reverse reaming is done several times (3–4 times in our experience) until the image intensifier shows a uniform distribution of graft all around the cavity. This procedure of serial reaming and associated reverse reaming helps to distribute the allograft uniformly across the cavity. Once the graft has been adequately impacted, a dynamic hip screw with side plate fixation is done. In cases where the physis was still open, we inserted the hip screw just short of it. Curetted samples are sent for histology to re-confirm the initial diagnosis.

In our series, tibial slices were predominantly used as allografts followed by femoral head slices in 31 cases (89%) and 4 cases (11%) respectively. In two patients who had a wide diameter of the femoral neck, we employed an additional fibular strut allograft to augment the defect. All patients had a routine physiotherapy protocol which included hip abductor strengthening exercises and non-weight mobilization walking for 4 weeks followed by a progressive increase in weight-bearing as tolerated. Patients were followed up at 3 months, 6 months, and at 1 year followed by yearly follow-ups. Radiographs were taken during each follow-up and functional outcomes were scored using Harris Hip Score (HHS) and Musculoskeletal tumour society (MSTS) score at 1 year and the last follow-up. Radiographs taken at follow-ups were assessed to see for radiolucency of the cavity filled with allografts to see for any recurrence.
Each radiograph taken during follow-up was assessed by an orthopaedic registrar and a radiology fellow to see for any signs of disease recurrence. The attenuation of allografts if any in the impacted cavity was noted for in the radiographs. All the follow-up radiographs were compared with the immediate postoperative radiograph and the scoring was done. If it was seen, then it was scored as ‘Yes’, otherwise it was scored as ‘No’. Any disagreement was settled by mutual discussion. All radiographs taken during follow-up were seen in PACS system and scoring was done.
3 Results
No patient was lost to follow-up. All 35 patients returned to full weight-bearing walking at 12.4 weeks (8–20) post-surgery. Thirty-four patients (97%) returned to unrestricted normal activity at the end of 6 months. Two patients (GCT = 1; fibrous dysplasia = 1) had a recurrence of the disease at 9 months and 12 months post-surgery, respectively. One of the patients with a diagnosis of FD had stable disease and was managed conservatively without progression of disease or aggravation of symptoms. The other patient, who had a tissue diagnosis of GCT, had a progressive increase of disease, which warranted a revision surgery involving a curettage and joint replacement as the femoral head could not be salvaged. At a mean follow-up of 41.5 months (23–80), all the remaining patients (94%), demonstrated favorable functional outcomes with a mean MSTS of 28.3 (18–30) and a mean HHS of 94.3 (66–100) at the last follow-up. All curetted samples during surgery sent for histology corresponded to the initial diagnosis made before surgery.
Radiographs showed consolidation and good incorporation of allografts with the parent bone in the remaining cases (n = 33), across all pathologies at the final follow-up (Fig. 2, Fig. 3 and Fig. 4). No patient sustained any pathological fracture or developed avascular necrosis of the femoral head.



Evaluation of the radiographs revealed a similar pattern of incorporation of allografts. During the 3-month follow-up, 42% (13/31) of the available radiographs showed increased lucency in the cavity of incorporated allografts and at the 6-month follow-up, 87.5% (28/32) of the available radiographs showed increased lucency compared to the initial post-operative radiograph. However, at 12 months follow-up, the radiographs showed the disappearance of lucency and good consolidation of allografts and integration to the parent bone (Fig. 3).
Two patients (6%) developed superficial infection post-surgery which healed with dressings and intravenous antibiotics. Two patients (6%) developed a temporary abductor lurch which resolved following supervised abductor-strengthening exercises. Only one patient complained about implant-related irritation during follow-up at 2 years for which implant removal gave him relief of symptoms (Fig. 5). Two patients had recurrence with one of them warranting revision surgery (Fig. 6).


4 Discussion
Our study shows favorable results while using allografts through impaction bone grafting to manage benign lesions of the femoral neck. To the best of our knowledge, this is the largest reported series of the use of only allografts in the management of such lesions. This is the central strength of our study. Our results show that IBG of allografts following extended curettage of benign proximal femur lesions provides adequate consolidation of the cavity and was successful in 94% of cases without any need for secondary procedures. Adding a fixation device provides better stability and also ensures favorable outcomes. Most importantly we used only a single lateral approach and the use of allografts avoided donor site morbidity associated with autograft use.
Benign lesions in the proximal femur offer extra challenges in management following curettage due to their unique anatomy. Lesions in that region significantly weaken the cortex and due to biomechanics involved in relationship with the hip joint,11,12 there is a higher chance of fracture if not managed appropriately. Another factor that is important to be considered is that these lesions usually occur in younger individuals. Young individuals who are active need to be managed appropriately to prevent a fracture following treatment. Hence, we used an internal fixation device after extended curettage as it offers better stability and the chances of fracture are minimized. The average age of patients in our study was 23.8 years and offering a fixation device after IBG in young active patients is associated with good functional outcomes as seen in our results. The use of a fixation device also helps in early weight-bearing as seen with our patients. George et al.1 who used only a non-vascularised fibula autograft strut to manage 17 cases, advocated their patients to unrestricted activity only around 12 months whereas in our series patients started full-weight bearing around 3 months after surgery and within 6 months, all our patients performed unrestricted activity.
The choice of grafts to reconstruct such defects has predominantly been autografts.1,3–6 Use of fibular autograft strut,1,4,6 use of iliac crest autografts3 and a combination of autografts and allografts5 have been advocated ay authors. However, autograft harvest is associated with occasional complications. Banwart et al.13 in their analysis of 261 consecutive patients, who underwent iliac crest harvest, reported 39% of minor complications including dysesthesia lasting more than 3 months. Fibula harvesting for usage is also associated with occasional complications.1,14 Lenze et al. showed a 5.6% incidence of transient peroneal nerve palsy after harvesting fibula.14 The use of only allografts can be a solution to avoid donor site morbidity but has been seldom reported. One of the reasons could be the lack of availability of allografts in treating centers. The versatility of usage and plentiful supply are other important advantages associated with allografts.15,16 The delivery of allografts into the curetted cavity in an adequate fashion can be challenging and hence the technique of IBG of morselized grafts is essential. Morselized grafts are easy to deliver into the cavity and the process of repeated reaming involved in IBG ensures tight packing of the contained cavity with grafts. This helps in the adequate reconstruction of the bone stock which is essential especially in young patients. No patient developed avascular necrosis during the latest follow-up which is also reassuring. Allografts have traditionally been shown to be associated with an increased infection rate, disease transmission, and reduced rate of incorporation.1,17 But with newer guidelines issued and stringent processes followed with regard to bone processing and irradiation,18 there has been a decrease in the incidence of adverse reactions. Gamma irradiation is one of the safest modes of sterilization of allografts to prevent disease transmission and is safe for clinical use.19 We employed such grafts in our series and no patient reported any allograft-related adverse complications and all patients had complete incorporation of the graft. Even in two patients in our series who had a wide femoral neck, we supplemented the cavity with a fibular allograft strut before inserting the implant. Both these patients went on to have complete incorporation of the strut and also associated good functional outcomes. Allografts mainly produce an osteoconductive matrix which when surrounded by fibrovascular granulation tissue undergoes vascular and osteogenic cell invasion leading to incorporation with parent bone.19,20 The rich vascular supply of the proximal femur is another important factor that helps in vascularisation and subsequent incorporation of allografts. However, it must be kept in mind that appropriate clearance of the disease by extended curettage is the most important factor of disease recurrence and this must be carefully and thoroughly done in each case. The two cases of recurrence in our series can mainly be attributed to the biology of the disease and probable disease clearance during the initial surgery.
The pattern of integration of allografts into parent bone as visualized in radiographs is different compared to other forms of bone grafts and substitutes. Allografts undergo creeping substitution which involves graft resorption followed by osseous incorporation. Radiographs taken during this time could show some lucency20,21 and this should not confuse treating clinicians to mistake this for recurrence. In our series, 41.9% of available radiographs during the 3-month follow-up period and 87.5% at 6-month follow-up, demonstrated increased radiolucency compared to the immediate postoperative radiograph. However, these patients were clinically asymptomatic and were kept on routine close follow-up. Subsequently, the radiographs of these patients showed good incorporation of allografts to parent bone and patients also demonstrated good functional outcomes. CT scans have been shown to analyze graft incorporation better,20,22 but however, the risks of associated radiation with it23 should be taken into consideration. Also in our technique of management, the presence of an implant would result in image scatter on scanning and would hinder the radiologist from making an accurate analysis. We strongly feel that radiographs are sufficient to monitor these cases with the background knowledge regarding the pattern of incorporation of allografts.
4.1 Limitations of our study
The retrospective nature of our study and single results are limitations of our study. The varied histological diagnosis of cases was not compared as cohorts due to the limited numbers, but however, all cases followed the same principle of management of extended curettage and reconstruction, and hence our results are a useful guide for clinicians managing such cases. The method of evaluation of radiographs employed in our study was subjective. Performing an objective method of assessment was not feasible with radiographs. We tried to increase the accuracy by involving two clinicians to evaluate the radiographs. Performing CT scans and measuring Hounsfield units could have been performed to analyze the integration of grafts better but we strongly feel that these investigations can be avoided due to the associated radiation risks involved, and hence we did not use them in our study. Newer treatment modalities for these benign lesions, including radiofrequency ablation, are shown to have a good effect in such cases. However, they were not employed as treatment methods in our series.
5 Conclusion
Management of benign lesions of the femoral neck offers extra challenges as they predominantly occur in young individuals and also due to associated biomechanics of the proximal femur. IBG of allografts after extended curettage combined with an implant offers good bony consolidation of the cavity, ensures better stability, and is associated with favorable outcomes. The transient lucency of allografts seen on post-operative radiographs must not alarm clinicians with regards to recurrence and these patients must be followed-up regularly.
Funding statement
This study was funded by Ganga Orthopaedic Research & Education Foundation (GOREF).
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Informed consent
All participants were informed regarding the use of their Images, and consent was obtained for their use in anonymity.
The study was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki.
Ethics approval
Institutional Review Board approval was obtained for this study and the same has been attached in the Supplementary documents.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Author contributions
RBR: Conception of the study, project administration, interpretation of data, writing of manuscript. DJ: Designed the study, Supervision, Review, and Editing of Draft. DRP: Designed the study, Review, and Editing of Draft. DA: Designed the study, suggested corrections in manuscript. PBT: Assisted in methodology and analysis of data, final approval of manuscript for submission. SR: Review and Editing of manuscript, final approval of manuscript for submission. All authors have read and approved the Manuscript.
References
- The treatment of benign lesions of the proximal femur with non-vascularised autologous fibular strut grafts. J Bone Joint Surg Br. May. 2008;90(5):648-651.
- [Google Scholar]
- Pathologic fractures of the proximal femur secondary to benign bone tumors. Clin Orthop Relat Res. Dec (393):279-286.
- [Google Scholar]
- Benign aggressive lesions of femoral head and neck: is salvage possible? Indian J Orthop. 2018;52(1):51-57.
- [Google Scholar]
- Use of a fibular allograft strut in the treatment of benign lesions of the proximal femur. Am J Orthop (Belle Mead NJ. Oct. 2002;31(10):575-578.
- [Google Scholar]
- Treatment of the femoral neck and trochanteric benign lesions. Clin Orthop Relat Res. Jul (328):220-226.
- [Google Scholar]
- Treatment of benign lesions of the femoral head and neck. Clin Orthop Relat Res. Aug (257):134-137.
- [Google Scholar]
- Impaction bone grafting and valgus osteotomy: a technical trick for the treatment of femoral neck nonunions. J Orthop Trauma. Oct. 2019;33(10):e403-e408.
- [Google Scholar]
- Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre. BMC Muscoskel Disord. 2021;22(1):18.
- [Google Scholar]
- Setting up a tissue bank in India: the tata memorial hospital experience. Cell Tissue Bank. 2003;4(2-4):193-201.
- [Google Scholar]
- Prediction of femoral fracture load using automated finite element modeling. J Biomech. 1998;31(2):125-133.
- [Google Scholar]
- New insights on the proximal femur biomechanics using Digital Image Correlation. J Biomech. 2020;101
- [Google Scholar]
- Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine. 1995;20(9):1055-1060.
- [Google Scholar]
- Non-vascularised fibula grafts for reconstruction of segmental and hemicortical bone defects following meta-/diaphyseal tumour resection at the extremities. BMC Muscoskel Disord. 2017;18(1):289.
- [Google Scholar]
- Autograft, allograft, and bone graft substitutes: clinical evidence and indications for use in the setting of orthopaedic trauma surgery. J Orthop Trauma. 2019;33(4):203-213.
- [Google Scholar]
- Management of resistant distal femur non-unions with allograft strut and autografts combined with osteosynthesis in a series of 22 patients. Injury. 2017;48(2):S14-S17.
- [Google Scholar]
- Bone allografts: what they can offer and what they cannot. J Bone Jt Surg Br Vol. 2007;89(5):574-579.
- [Google Scholar]
- Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop. 2012;36(3):633-641.
- [Google Scholar]
- Radiation sterilization of tissue allografts: a review. World J Radiol. 2016;8(4):355-369.
- [Google Scholar]
- Imaging characteristics of bone graft materials. Radiographics : Rev Pub Radiol Soc North Am Inc. 2006;26(2):373-388.
- [Google Scholar]
- Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater. 2017;2(4):224-247.
- [Google Scholar]
- A surgical algorithm for the management of recalcitrant distal femur nonunions based on distal femoral bone stock, fracture alignment, medial void, and stability of fixation. Arch Orthop Trauma Surg. 2019;139(8):1057-1068.
- [Google Scholar]
- Computed tomography and patient risk: facts, perceptions and uncertainties. World J Radiol. 2016;8(12):902-915.
- [Google Scholar]

